The Use of Glucocorticoid in the Management of Adverse Effects Related to Immunocheckpoint Inhibitors
Immunocheckpoint inhibitors (ICIs) activated the patients’ tumor immunity to kill the tumor cell, and brought new hope to patients with tumor. However, a series of immunocheckpoint inhibitors related adverse effects (irAEs) may also occur based on immune injury. Glucocorticoids are the basis for the...
Main Authors: | Hanping WANG, Jiaxin ZHOU, Xiaoxiao GUO, Yue LI, Lian DUAN, Xiaoyan SI, Li ZHANG |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2019-10-01
|
Series: | Chinese Journal of Lung Cancer |
Subjects: | |
Online Access: | http://dx.doi.org/10.3779/j.issn.1009-3419.2019.10.02 |
Similar Items
-
Clinical Diagnosis and Treatment of Immune-related Adverse Events in Digestive System Related to Immune Checkpoint Inhibitors
by: Yue LI, et al.
Published: (2019-10-01) -
Clinical Diagnosis and Treatment Recommendations for Cardiac Adverse Reactions Related to Immune Checkpoint Inhibitor
by: Xiaoxiao GUO, et al.
Published: (2019-10-01) -
Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor‐related adverse reactions in the nervous system
by: Jiayu Shi, et al.
Published: (2020-02-01) -
Clinical manifestation and management of immune checkpoint inhibitor‐associated cardiotoxicity
by: Xiaoxiao Guo, et al.
Published: (2020-02-01) -
Impact of Glucocorticoid Use in Oncology in the Immunotherapy Era
by: Laura Kalfeist, et al.
Published: (2022-02-01)